Mostrar el registro sencillo del ítem

Artículo

dc.creatorGarrido-Maraver, Juanes
dc.creatorCordero, Mario D.es
dc.creatorOropesa-Ávila, Manueles
dc.creatorFernández Vega, Alejandroes
dc.creatorMata, Mario de laes
dc.creatorDelgado Pavón, Anaes
dc.creatorMiguel Rodríguez, Manuel dees
dc.creatorSánchez-Alcázar, José Antonioes
dc.date.accessioned2023-02-08T13:32:18Z
dc.date.available2023-02-08T13:32:18Z
dc.date.issued2014
dc.identifier.citationGarrido-Maraver, J., Cordero, M.D., Oropesa-Ávila, M., Fernández Vega, A., Mata, M.d.l., Delgado Pavón, A.,...,Sánchez-Alcázar, J.A. (2014). Coenzyme Q(10) Therapy. Molecular Syndromology, 5 (3-4), 187-197. https://doi.org/10.1159/000360101.
dc.identifier.issn1661-8769es
dc.identifier.issn1661-8777 (online)es
dc.identifier.urihttps://hdl.handle.net/11441/142548
dc.description.abstractFor a number of years, coenzyme Q 10 (CoQ 10 ) was known for its key role in mitochondrial bioenergetics; later studies demonstrated its presence in other subcellular fractions and in blood plasma, and extensively investigated its antioxidant role. These 2 functions constitute the basis for supporting the clinical use of CoQ 10 . Also, at the inner mitochondrial membrane level, CoQ 10 is recognized as an obligatory cofactor for the function of uncoupling proteins and a modulator of the mitochondrial transition pore. Furthermore, recent data indicate that CoQ 10 affects the expression of genes involved in human cell signaling, metabolism and transport, and some of the effects of CoQ 10 supplementation may be due to this property. CoQ 10 deficiencies are due to autosomal recessive mutations, mitochondrial diseases, aging-related oxidative stress and carcinogenesis processes, and also statin treatment. Many neurodegenerative disorders, diabetes, cancer, and muscular and cardiovascular diseases have been associated with low CoQ 10 levels as well as different ataxias and encephalomyopathies. CoQ 10 treatment does not cause serious adverse effects in humans and new formuhave been developed that increase CoQ 10 absorption and tissue distribution. Oral administration of CoQ 10 is a frequent antioxidant strategy in many diseases that may provide a significant symptomatic benefit.es
dc.formatapplication/pdfes
dc.format.extent11 p.es
dc.language.isoenges
dc.publisherKARGERes
dc.relation.ispartofMolecular Syndromology, 5 (3-4), 187-197.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectClinical indicationses
dc.subjectCoenzyme Q 10es
dc.subjectCoenzyme Q 10 -related compoundses
dc.subjectPharmacokineticses
dc.titleCoenzyme Q(10) Therapyes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Citología e Histología Normal y Patológicaes
dc.relation.projectIDFIS PI10/00543es
dc.relation.projectIDFIS EC08/00076es
dc.relation.projectIDSAS 111242es
dc.relation.publisherversionhttps://www.karger.com/Article/FullText/360101es
dc.identifier.doi10.1159/000360101es
dc.journaltitleMolecular Syndromologyes
dc.publication.volumen5es
dc.publication.issue3-4es
dc.publication.initialPage187es
dc.publication.endPage197es
dc.contributor.funderMinisterio de Sanidad. Españaes
dc.contributor.funderServicio Andaluz de Salud. Junta de Andalucíaes

FicherosTamañoFormatoVerDescripción
Coenzyme...pdf323.0KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional